Amadeus Integrates IBM Digital Health Pass Into Its Digital Health Verification Technology

IBMIBM (NYSE: IBM) and Amadeus (MCE: AMS) announced that they are working together to help meet one of the major challenges facing travel companies today: checking and validating the COVID-19 health documentation of travelers at checkpoints where required.

As part of that effort, IBM Digital Health Pass is now integrated into Traveler ID for Safe Travel, Amadeus' digital health verification solution. This enables airlines to integrate the use of COVID-19 digital health credentials into their existing reservation and booking system, allowing airline passengers the option to scan or upload documentation to show their health credentials.

As passengers move through the online check-in process, Traveler ID for Safe Travel checks the requirements for that particular trip against destination country regulations. This then prompts passengers with the option to generate a secure COVID-19 digital credential by scanning paper documents or uploading a digital version from their mobile or desktop.

These COVID-19 digital health credentials are then verified using IBM Digital Health Pass, which uses a combination of encryption and blockchain technologies to authenticate COVID-19 health credentials against a global ecosystem of labs, vaccination centers and healthcare providers. Airlines receive a simple status confirming a passenger is ready to fly. This secure approach provides passenger privacy since only the compliance with border entry requirements is confirmed; no personal health information is stored by the airline, IBM, or Amadeus.

"While countries across the globe are beginning to slowly reopen borders to welcome back visitors, specific border entry requirements may vary greatly country to country. The need to check COVID-19 health documentation is causing significant delays during the journey for airlines and other travel providers, as well as the traveler," said Greg Land, Travel and Transportation Industry Lead, IBM. "The integration of IBM Digital Health Pass into Amadeus' Traveler ID for Safe Travel is designed to provide airlines with open technologies they can build into existing digital solutions. This can help airlines safely meet border entry requirements while delivering a smoother customer experience."

"The integration with IBM is a step-change for Traveler ID for Safe Travel. The combination of the IBM Digital Health Pass with our Traveler ID for Safe Travel technology means that COVID-19 health documents can be digitized and read, verified, and authenticated. This avoids cumbersome and time-consuming checks while traveling, and adds further reassurance to airlines and their passengers," said Christian Warneck, VP Safe Travel Ecosystem, Amadeus. "This is another milestone in the collaboration we are driving through our Safe Travel Ecosystem. By working hand in hand with customers and partners such as IBM, we can deliver the capabilities needed by travel providers and travelers to help provide a smooth passenger journey once more."

Traveler ID for Safe Travel is currently live with multiple airlines, with additional airline customers to be announced soon. Traveler ID's digital identity and health verification capabilities are also relevant for other customer groups, including hotels and airports.

About IBM

For more information about IBM visit, www.ibm.com.

About Amadeus

Travel powers progress. Amadeus powers travel. Amadeus' solutions connect travelers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways. We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries. We are one company, with a global mindset and a local presence wherever our customers need us. Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.

Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognized by the Dow Jones Sustainability Index for the last eight years.

To find out more about Amadeus, visit www.amadeus.com.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...